These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives. Salzano A; D'Assante R; Heaney LM; Monaco F; Rengo G; Valente P; Pasquali D; Bossone E; Gianfrilli D; Lenzi A; Cittadini A; Marra AM; Napoli R Endocrine; 2018 Aug; 61(2):194-203. PubMed ID: 29572708 [TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and its association with metabolic syndrome components. Medeiros CC; Ramos AT; Cardoso MA; França IS; Cardoso Ada S; Gonzaga NC Arq Bras Cardiol; 2011 Nov; 97(5):380-9. PubMed ID: 21971636 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Verhagen SN; Wassink AM; van der Graaf Y; Gorter PM; Visseren FL; Cardiovasc Diabetol; 2011 Nov; 10():100. PubMed ID: 22098712 [TBL] [Abstract][Full Text] [Related]
5. [Insulin resistance and metabolic syndrome in type 1 diabetes mellitus]. Dib SA Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):250-63. PubMed ID: 16767291 [TBL] [Abstract][Full Text] [Related]
6. Predictors of cardiovascular risk among patients with type 1 diabetes: A critical analysis of the metabolic syndrome and its components. Gingras V; Leroux C; Fortin A; Legault L; Rabasa-Lhoret R Diabetes Metab; 2017 Jun; 43(3):217-222. PubMed ID: 28139436 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk associated with the metabolic syndrome. Lindsay RS; Howard BV Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282 [TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance. DESIRE study]. Goday A; Gabriel R; Ascaso JF; Franch J; Ortega R; Martínez O; Lerones N; Rev Clin Esp; 2008 Sep; 208(8):377-85. PubMed ID: 18817695 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients. Forst T; Hohberg C; Pfützner A Horm Metab Res; 2009 Feb; 41(2):123-31. PubMed ID: 19214922 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes. Krishnan S; Short KR J Cardiometab Syndr; 2009; 4(1):50-6. PubMed ID: 19245517 [TBL] [Abstract][Full Text] [Related]
12. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease. Reaven G Clin Chem; 2008 May; 54(5):785-7. PubMed ID: 18375479 [No Abstract] [Full Text] [Related]
13. Insulin resistance and hyperglycaemia in cardiovascular disease development. Laakso M; Kuusisto J Nat Rev Endocrinol; 2014 May; 10(5):293-302. PubMed ID: 24663222 [TBL] [Abstract][Full Text] [Related]
14. [Metabolic syndrome in patients with diabetes mellitus type 1, prevalence, impact on morbidity and mortality]. Brožová J; Čechurová D; Lacigová S Vnitr Lek; 2016; 62(11 Suppl 4):S8-14. PubMed ID: 27921419 [TBL] [Abstract][Full Text] [Related]
15. [Visceral fat and metabolic syndrome: more than a simple association]. Ribeiro Filho FF; Mariosa LS; Ferreira SR; Zanella MT Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):230-8. PubMed ID: 16767289 [TBL] [Abstract][Full Text] [Related]
16. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pucci G; Alcidi R; Tap L; Battista F; Mattace-Raso F; Schillaci G Pharmacol Res; 2017 Jun; 120():34-42. PubMed ID: 28300617 [TBL] [Abstract][Full Text] [Related]
17. Unraveling the mysteries of syndrome X. As the number of Americans with insulin resistance grows, pharmacists can help patients prevent the onset of type 2 diabetes and cardiovascular disease. Campbell RK J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S32-3. PubMed ID: 14626524 [TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population. Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid. Aminot-Gilchrist DV; Anderson HD Am J Clin Nutr; 2004 Jun; 79(6 Suppl):1159S-1163S. PubMed ID: 15159251 [TBL] [Abstract][Full Text] [Related]
20. Insulin dose and cardiovascular risk factors in type 1 diabetic children and adolescents. Balkau B; Tichet J; Caces E; Vol S; Eschwege E; Cahane M Diabetes Metab; 1998 Apr; 24(2):143-50. PubMed ID: 9592639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]